Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹395 Cr₹365 Cr₹262 Cr₹216 Cr₹194 Cr

What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹395 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹395 Cr
Mar2025₹365 Cr
Mar2024₹262 Cr
Mar2023₹216 Cr
Mar2022₹194 Cr

How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2026 ₹395 Cr
8.05
Mar2025 ₹365 Cr
39.19
Mar2024 ₹262 Cr
21.26
Mar2023 ₹216 Cr
11.40
Mar2022 ₹194 Cr -

Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹257.4 Cr -3.1% -11.2% -16.8% Stock Analytics
KAVERI SEED COMPANY ₹3,496.6 Cr -5% -7.3% -32.9% Stock Analytics
VENKYS (INDIA) ₹2,266.7 Cr 0.2% -2.2% 11% Stock Analytics
AVT NATURAL PRODUCTS ₹1,300.8 Cr -2.8% -5.4% 21.4% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹824.5 Cr -7.6% -15.5% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹520.4 Cr 2.9% -0.5% -9.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.1%

-11.2%

-16.8%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses